Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 1 | — | — |
malaise; Lymphadatitis; high inflammation; high fever; This non-serious spontaneous safety report, with reference number 02733834 (interaction number: 02733830), was received by partner on 10-JAN-2025 and forwarded to UBC on 13-JAN-2025 from physician. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events, 'high fever, malaise, lymphadenitis, and high inflammation'. Further information is not expected. Non-significant follow-up information was received via email on 27-JAN-2025, from a physician. The case is maintained as non-serious. Further information is not expected.
Prophylaxis